GB9916794D0 - In vitro virus reconstitution - Google Patents

In vitro virus reconstitution

Info

Publication number
GB9916794D0
GB9916794D0 GBGB9916794.2A GB9916794A GB9916794D0 GB 9916794 D0 GB9916794 D0 GB 9916794D0 GB 9916794 A GB9916794 A GB 9916794A GB 9916794 D0 GB9916794 D0 GB 9916794D0
Authority
GB
United Kingdom
Prior art keywords
vitro virus
virus reconstitution
reconstitution
vitro
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9916794.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB9916794.2A priority Critical patent/GB9916794D0/en
Publication of GB9916794D0 publication Critical patent/GB9916794D0/en
Priority to PT00946097T priority patent/PT1194580E/pt
Priority to DE122008000056C priority patent/DE122008000056I1/de
Priority to DE122008000057C priority patent/DE122008000057I1/de
Priority to DE60033284.5T priority patent/DE60033284T3/de
Priority to DE200712000070 priority patent/DE122007000070I1/de
Priority to DE201112100041 priority patent/DE122011100041I1/de
Priority to DK00946097.3T priority patent/DK1194580T4/da
Priority to AU59984/00A priority patent/AU5998400A/en
Priority to DE200712000061 priority patent/DE122007000061I2/de
Priority to JP2001509537A priority patent/JP4850375B2/ja
Priority to AT00946097T priority patent/ATE353370T1/de
Priority to PCT/GB2000/002710 priority patent/WO2001004333A1/en
Priority to CA2379012A priority patent/CA2379012C/en
Priority to EP00946097A priority patent/EP1194580B2/en
Priority to ES00946097T priority patent/ES2278621T5/es
Priority to CY20071100397T priority patent/CY1106404T1/el
Priority to NL300301C priority patent/NL300301I2/nl
Priority to LU91367C priority patent/LU91367I2/fr
Priority to CY200700023C priority patent/CY2007023I1/el
Priority to NL300294C priority patent/NL300294I2/nl
Priority to NL300368C priority patent/NL300368I2/nl
Priority to NL300369C priority patent/NL300369I1/nl
Priority to FR08C0046C priority patent/FR08C0046I2/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB9916794.2A 1999-07-14 1999-07-16 In vitro virus reconstitution Ceased GB9916794D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GBGB9916794.2A GB9916794D0 (en) 1999-07-16 1999-07-16 In vitro virus reconstitution
ES00946097T ES2278621T5 (es) 1999-07-14 2000-07-14 Reconstrucción in vitro de virus arn segmentados de polaridad negativa.
JP2001509537A JP4850375B2 (ja) 1999-07-14 2000-07-14 分節化した（−）鎖ＲＮＡウイルスのｉｎｖｉｔｒｏ再構築
PCT/GB2000/002710 WO2001004333A1 (en) 1999-07-14 2000-07-14 In vitro reconstitution of segmented negative-strand rna viruses
DE122008000057C DE122008000057I1 (de) 1999-07-14 2000-07-14 In vitro-rekonstitution von segmentierten negativstrang-rna-viren
DE60033284.5T DE60033284T3 (de) 1999-07-14 2000-07-14 In vitro-rekonstitution von segmentierten, negativstrang-rna-viren
DE200712000070 DE122007000070I1 (de) 1999-07-14 2000-07-14 In Vitro-rekonstitution von segmentierten Negativstrang-Rna-Viren
DE201112100041 DE122011100041I1 (de) 1999-07-14 2000-07-14 In vitro-rekonstitution von segmentierten, negativstrang-rna-viren.
DK00946097.3T DK1194580T4 (da) 1999-07-14 2000-07-14 In-vitro rekonstitution af segmenterede negativstrengede RNA-virus
AU59984/00A AU5998400A (en) 1999-07-14 2000-07-14 In vitro reconstitution of segmented negative-strand rna viruses
DE200712000061 DE122007000061I2 (de) 1999-07-14 2000-07-14 In vitro-rekonstitution von segmentierten negativstrang-rna-viren.
PT00946097T PT1194580E (pt) 1999-07-14 2000-07-14 Recostituição in victro de vírus de rna de cadeia negativa segmentados
AT00946097T ATE353370T1 (de) 1999-07-14 2000-07-14 In vitro-rekonstitution von segmentierten, negativstrang-rna-viren
DE122008000056C DE122008000056I1 (de) 1999-07-14 2000-07-14 In vitro-rekonstitution von segmentierten negativstrang-rna-viren
CA2379012A CA2379012C (en) 1999-07-14 2000-07-14 In vitro reconstitution of segmented negative-strand rna viruses
EP00946097A EP1194580B2 (en) 1999-07-14 2000-07-14 In vitro reconstitution of segmented negative-strand rna viruses
CY20071100397T CY1106404T1 (el) 1999-07-14 2007-03-20 Epγαστηριακη επανασυνθεση υποδιηρημενων σε τομεις αρνητικης ελικος rna ιων
NL300301C NL300301I2 (nl) 1999-07-14 2007-09-21 In vitro reconstitutie van RNA-virussen met een gesegmenteerde negatieve streng
LU91367C LU91367I2 (fr) 1999-07-14 2007-09-21 Un vaccin à virus complet de l'influenza inactivéepréparé à partir d'une souche germe produite en u tlilisant la génétique inverse et facultativement comprenant un adjuvant
CY200700023C CY2007023I1 (el) 1999-07-14 2007-09-21 Epγαστηριακη επανασυνθεση υποδιηρημενων σε τομεις αρνητικης ελικος rna ιων
NL300294C NL300294I2 (nl) 1999-07-14 2007-09-21 In vitro reconstitutie van RNA-virussen met een gesegmenteerde negatieve streng
NL300368C NL300368I2 (nl) 1999-07-14 2008-11-13 Geïnactiveerd split influenzavirus van influenzastam A/Indonesia/05/2005 (H5N1) (PR8-IBCDC-RG2), desgewenst van een pandemische influenzastam in een officieel verklaarde pandemische situatie
NL300369C NL300369I1 (nl) 1999-07-14 2008-11-13 In vitro reconstitutie van RNA-virussen met een gesegmenteerde negatieve streng
FR08C0046C FR08C0046I2 (fr) 1999-07-14 2008-11-13 Reconstitution in vitro de virus a arn de polarite negative segmentes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9916794.2A GB9916794D0 (en) 1999-07-16 1999-07-16 In vitro virus reconstitution

Publications (1)

Publication Number Publication Date
GB9916794D0 true GB9916794D0 (en) 1999-09-22

Family

ID=10857427

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9916794.2A Ceased GB9916794D0 (en) 1999-07-14 1999-07-16 In vitro virus reconstitution

Country Status (4)

Country Link
JP (1) JP4850375B2 (https=)
DE (1) DE122011100041I1 (https=)
GB (1) GB9916794D0 (https=)
PT (1) PT1194580E (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
ES2496315T3 (es) * 2005-10-19 2014-09-18 University Of Florida Research Foundation, Incorporated Materiales para el control de la enfermedad respiratoria en caninos
WO2011012999A1 (en) * 2009-07-31 2011-02-03 Novartis Ag Reverse genetics systems
CN102741399A (zh) * 2009-10-20 2012-10-17 诺华有限公司 用于病毒拯救的改良反向遗传方法
US9982240B2 (en) * 2012-08-03 2018-05-29 Sanofi Pasteur Production of infectious influenza viruses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1820853B1 (en) * 1999-04-06 2011-09-21 Wisconsin Alumni Research Foundation Recombinant influenza viruses for vaccines and gene therapy

Also Published As

Publication number Publication date
PT1194580E (pt) 2007-03-30
DE122011100041I1 (de) 2011-11-10
JP2003520573A (ja) 2003-07-08
JP4850375B2 (ja) 2012-01-11

Similar Documents

Publication Publication Date Title
BE2018C020I2 (https=)
BE2015C057I2 (https=)
BE2016C007I2 (https=)
BE2015C018I2 (https=)
BE2014C017I2 (https=)
BE2013C051I2 (https=)
BE2013C020I2 (https=)
BE2013C015I2 (https=)
BE2013C001I2 (https=)
BE2012C036I2 (https=)
BE2008C046I2 (https=)
BE1025464I2 (https=)
BE2010C011I2 (https=)
BRPI0017527B8 (https=)
JP2002520147A5 (https=)
BE2008C047I2 (https=)
BE2011C004I2 (https=)
BRPI0001672A2 (https=)
BRPI0001542A2 (https=)
JP2002533005A5 (https=)
DE60015325D1 (en) Offset-kompensation in analog-digital wandlern
BRPI0012675B8 (https=)
GB9916794D0 (en) In vitro virus reconstitution
BRPI0017522A2 (https=)
GB0029783D0 (en) Arrangement in moving crusher

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)